What Flouria does

Flouria (legal entity: Flouria Health B.V.) is a Netherlands-based digital women's health clinic that sells structured, condition-specific 'care paths' for perimenopause, postmenopause, fertility, and postpartum health. Each care path bundles hormone and blood testing, specialist consultations, a personalized treatment plan (including HRT prescriptions where applicable), prescription delivery, and 12 months of in-app support, priced at €395–€595 per path upfront or via 12-month installments. The platform is anchored by a mobile app (iOS and Android) built on Daily.co video, Stripe payments, Customer.io lifecycle messaging, Postmark email, and Google Cloud hosting, with physical testing delivered through a partnership with LabPlusArts across 750+ Dutch locations. Flouria operates exclusively within the Netherlands and is incorporated in Amsterdam.

The company sells through two go-to-market motions that share the same clinical product. Direct-to-consumer acquisition runs via a free online intake, SEO/content marketing (a 40+ article blog), webinars, and PR in Dutch media (MT/Sprout, FD, BNR), driving individuals to self-serve purchase through the website or app. A B2B2C motion, 'Flouria for Employers,' resells care paths to Dutch employers as an employee benefit at the same €395–€595 per-employee price point, with HR scheduling sales meetings via Calendly; employers receive aggregated engagement data but no individual employee health information. Flouria cites an €11 billion annual Dutch employer cost from women's-health-related absenteeism as the anchor market-size narrative.

Flouria was founded in 2024 by Jeanine van Munster alongside co-founders motivated by personal experiences with infertility, miscarriage, and premature ovarian insufficiency. The company is privately held, has raised a single disclosed $108,828 pre-seed round from Antler (March 2024), employs 1–10 people, and has assembled a clinical bench spanning fertility, endocrinology, menopause, and lifestyle medicine. There are no disclosed institutional investors beyond Antler, no patents, no awards, and no revenue disclosure, indicating a bootstrapped-or-near-bootstrap early-stage FemTech operator.

Name

Flouria

Legal name

Flouria Health B.V.

Website

https://flouria.health

Company type

Private

Founded year

2024

Operating status

Operating

Headcount range

1–10 employees

Short description

Flouria is a Netherlands-based digital women's health clinic selling structured perimenopause, postmenopause, fertility, and postpartum care paths to individual consumers and Dutch employers via a mobile app and B2B2C benefit channel.

Ownership category

akta.pro rank

Product category

Digital Women's Health

akta.pro primary industry

Prenatal, Postpartum & Fertility Nutrition (HSADAFAK)

Keywords

• Digital health clinic
• Women's health platform
• Menopause care
• Fertility services
• Postpartum support

Headquarters

HQ city

Amsterdam

HQ country

Netherlands

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Care Path Subscriptions: Subscription-based care paths (perimenopause, postmenopause, fertility, postpartum) purchased upfront or via monthly payment plans. Includes testing, consultations, personalised treatment plans, prescriptions, and app access for 1 year.
2. Employer Sponsored Access: B2B2C model where employers pay for employee access to Flouria as an employee benefit, with care paths costing between €395-595 per employee.

Pricing tiers

Go-to-market motion3 records

Distribution channels3 records

Marketing channels7 records

Core offering

Flouria is a digital women's health clinic that sells structured care paths for perimenopause, fertility, postpartum, and postmenopause delivered through a mobile application. Each care path combines hormone and blood testing (via partner LabPlusArts), video consultations with BIG-registered women's health specialists, personalized treatment plans including HRT prescriptions delivered to the patient's doorstep, and ongoing in-app support with symptom/cycle tracking and educational content. Beyond individual subscriptions (€395–€595 per path), Flouria sells a B2B employee benefit program to Dutch employers.

Product overview

Flouria is a digital women's health clinic offering a platform-plus-multiple-care-paths architecture. The core Flouria App serves as the central hub enabling symptom tracking, video consultations, and access to personalized treatment plans. The company provides four specialized care paths—Perimenopause, Fertility, Postpartum, and Postmenopause—each combining hormone and blood testing via partner Labplusarts, expert doctor consultations via Daily.co video platform, personalized treatment plans including HRT prescriptions, and ongoing support through in-app chat and prescription delivery. Additionally, Flouria for Employers offers a B2B employee benefit tier, and the Women's Health Blog provides educational content. Pricing for individual care paths ranges from €395-595 upfront or €55/month on a 12-month plan.

Differentiator

Problem solved

Functional benefit

Products and services

• Flouria App Mobile application serving as the central hub for all Flouria services, enabling symptom tracking, chat and video consultations with doctors, access to personalised care plans, and medically-vetted educational content and courses.
• Perimenopause Care Path Personalised, doctor-led care program for women in perimenopause combining hormone and blood testing, expert consultations, symptom tracking, and tailored treatment plans including HRT prescriptions delivered to the doorstep.
• Fertility Care Path Medical support from specialised fertility doctors including testing, insights, and personalised treatment plans for women seeking conception support.
• Postpartum Care Path Specialised care program for women recovering from childbirth, offering hormone testing, consultations with women's health experts, and treatment plans for postpartum hormonal symptoms.
• Postmenopause Care Path Care program for women in postmenopause providing specialised medical support, testing, and ongoing treatment plans for menopausal symptoms and health management.
• Flouria for Employers B2B employee benefit program enabling organisations to provide women's health support to their female employees, including video consultations, testing, treatment, awareness events, and engagement measurement.

Quantifiable outcome

• 81% of women experience hormonal complaints that impact their productivity
• +2 more outcomes

Named customers5 records

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration5 records

Feature3 records

Partnerships

Ten partnerships are on record, tiered core and supporting.

• LabPlusArtscoreStrategic or Co-development PartnerLaboratory partner providing blood and hormone testing services with 750+ testing locations across The Netherlands. Patients receive test invitations through Flouria and visit LabPlusArts locations for sample collection.
• Pharmacy PartnercoreStrategic or Co-development PartnerPrescription delivery partner that delivers hormone therapy and other prescriptions to patients' doorsteps. Part of the comprehensive care path service.
• Daily.cocoreTechnology or IntegrationTechnology vendor providing video consultation infrastructure for the Flouria platform, enabling secure video calls between patients and healthcare providers.
• StripecoreTechnology or IntegrationPayment processing vendor handling online transactions for care path purchases and subscription payments.
• GooglesupportingTechnology or IntegrationTechnology vendor providing cloud hosting for platform data, email services, website analytics, and spam/misuse protection.
• PostmarksupportingTechnology or IntegrationEmail service provider for account and appointment confirmation emails to users.
• Customer.iosupportingTechnology or IntegrationLifecycle and care-related communication platform for user engagement and communication throughout the care journey.
• MixpanelsupportingTechnology or IntegrationProduct analytics platform for understanding user behavior and improving the Flouria app experience.
• SentrysupportingTechnology or IntegrationError monitoring and crash reporting service for the Flouria app to identify and resolve technical issues.
• WeWorksupportingStrategic or Co-development PartnerOffice space provider for Flouria's headquarters in Amsterdam city centre, with flexible workspace and amenities.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Maven Clinic: Maven Clinic is a virtual women's and family health platform offering care across fertility, postpartum, and menopause to consumers and employers via a B2B2C benefit model — directly parallel to Flouria's positioning, with broader geography.
• Peppy Health: Peppy Health is a UK-based digital health platform delivering employer-sponsored menopause, fertility, and postpartum support via specialist messaging and consultations — the closest European-headquartered peer to Flouria's employer-care-paths model.
• Tia: Tia operates women's health clinics combining in-person and virtual care across reproductive, hormonal, and mental health needs — comparable care-path architecture (intake → consult → prescription) targeting a similar female patient demographic.
• Carrot Fertility: Carrot Fertility provides employer-sponsored fertility, family-forming, and hormonal health benefits globally — overlapping with Flouria's employer-B2B2C motion, particularly around fertility and menopause extensions.

Broad incumbents

• Progyny: Progyny is a publicly-traded fertility and women's reproductive health benefits provider sold primarily to large US employers — a broader incumbent offering employer-sponsored reproductive care with overlapping benefit-broker channels to Flouria.

Emerging players

• Elektra Health: Elektra Health is a US-based digital menopause care platform offering virtual specialist consults, education, and community — a focused emerging player in the menopause segment that directly parallels Flouria's perimenopause/postmenopause care paths.
• The Midi: The Midi (previously Gennev) is a virtual clinic specializing in perimenopause and menopause care with clinician-led protocols and prescription support — an emerging direct competitor to Flouria's hormonal-health care paths.
• Alife Health: Alife Health is a fertility-focused technology and clinical platform serving patients and providers — emerging competitor overlapping with Flouria's Fertility care path and broader reproductive-health data positioning.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/flouriahealth
• YouTubeyoutube.com/@flouria
• LinkedInlinkedin.com/company/flouria
• Instagraminstagram.com/flouria.health
• Facebookfacebook.com/flouria.health

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Flouria